Hill-Rom (NYSE:HRC) Issues Q4 2019 Earnings Guidance

Hill-Rom (NYSE:HRC) updated its fourth quarter 2019 earnings guidance on Friday. The company provided EPS guidance of $1.64-1.66 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.67. Hill-Rom also updated its FY 2019 guidance to $5.03-5.05 EPS.

Several equities research analysts recently weighed in on the company. Barclays increased their price target on Hill-Rom from $103.00 to $108.00 and gave the stock an equal weight rating in a report on Monday, April 15th. ValuEngine downgraded Hill-Rom from a buy rating to a hold rating in a report on Thursday. Finally, Zacks Investment Research raised Hill-Rom from a hold rating to a buy rating and set a $103.00 target price for the company in a report on Thursday, June 6th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Hill-Rom has an average rating of Buy and an average price target of $107.50.

Shares of HRC stock traded down $4.04 during mid-day trading on Friday, reaching $103.92. The stock had a trading volume of 694,227 shares, compared to its average volume of 324,414. Hill-Rom has a 12-month low of $81.82 and a 12-month high of $109.18. The firm has a market capitalization of $7.21 billion, a P/E ratio of 21.88, a P/E/G ratio of 1.86 and a beta of 0.90. The firm’s 50-day moving average is $105.40. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.27 and a current ratio of 1.69.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, August 2nd. The medical technology company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.02. The business had revenue of $726.80 million during the quarter, compared to analysts’ expectations of $718.08 million. Hill-Rom had a return on equity of 21.30% and a net margin of 7.93%. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the business posted $1.15 earnings per share. On average, equities analysts forecast that Hill-Rom will post 5.04 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Friday, September 20th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Thursday, September 19th. Hill-Rom’s dividend payout ratio is presently 17.68%.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: What is a blue-chip stock?

Earnings History and Estimates for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.